passa a ser limitado, pois essa síndrome gera sinais e sintomas localizados no membro acometido, podendo também se estabelecer em outros locais. Tendo isso em vista, este estudo objetiva apresentar as contribuições da Terapia Ocupacional e do Programa de Reabilitação Baseado no Estresse Muscular de Tração e Compressão Ativa para um sujeito com SCDR I no membro superior, atendido pelo Grupo de Dor do Hospital Universitário de Santa Maria (HUSM), RS. A presente pesquisa é caracterizada como um estudo de caso, experimental, que se ocupa dos períodos pré e pós-intervenção terapêutica ocupacional. Os instrumentos utilizados para coleta de dados foram os protocolos de Disfunção Ombro, Braço, Mão (DASH), a Classificação Internacional de Incapacidade, Funcionalidade e Saúde (CIF), a Medida Canadense de Desempenho Ocupacional (COPM), a Goniometria e a Escala Visual Analógica (EVA). Findas as avaliações, o sujeito foi exposto ao tratamento de exercícios ativos resistivos compressivos e, após a conclusão do tratamento, foi reavaliado. Observou-se, então, que o tratamento aplicado contribuiu para a diminuição do quadro doloroso e para a melhoria na Amplitude de Movimento (ADM) do sujeito. A utilização do protocolo de estresse e compressão ativa contribuiu significativamente para a redução da dor, o ganho de ADM e a melhora do desempenho ocupacional.
Editor,A recent discussion amongst us to improve the methods of scheduling operations led us to re-analyse the original data presented in the recent model. 1 This revealed small errors in four of the 153 data points published in our article. These were due to incorrectly labelled scheduled surgical list times (i.e. a half-day list mislabelled as full day and vice versa; two errors) and incorrectly applied gap 0265-0215 ß Re-plot of Fig. 4a of the original article: the degree of over-run (or under-run, negative values) vs. the calculated probability of over-run or under-run. (The original data for lists with cancellations are excluded here.)Eur 9 Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth 2011; 107:48-56. 10 Lister D, Hall GM, Lucke JN. Porcine malignant hyperthermia. III: Adrenergic blockade. Br J Anaesth 1976; 48:831-838. 11 Glahn KP, Ellis FR, Halsall PJ, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 2010; 105:417-420. 12 Birgenheier N, Stoker R, Westenskow D, Orr J. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
Rev Bras Cir Cardiovasc | Braz J Cardiovasc SurgRev Bras Cir Cardiovasc 2013;28(2):183-9 Silva LLM, et al. -Impact of autologous blood transfusion on the use of pack of red blood cells in coronary artery bypass grafting surgery RBCCV 44205-1456 DOI: 10.5935/1678 Impact of autologous blood transfusion on the use of pack of red blood cells in coronary artery bypass grafting surgery Impacto da transfusão autóloga no uso de concentrado de hemácias em cirurgias de revascularização do miocárdio INTRODUCTIONCardiovascular diseases are the leading causes of mortality not only in Brazil but also throughout the world [1,2], with acute myocardial infarction (AMI) being the main cause of death. The AMI surgical treatment through coronary artery bypass grafting surgery is an usual procedure, which is frequently associated with cardiopulmonary bypass (CPB) and high rates of homologous blood transfusion, varying from 40 to 90% in most publications [3][4][5]. Transfusion therapy is associated with several unfavorable outcomes, such as renal dysfunction, cardiac, neurological and immunological complications, among others [6].There is no consensus regarding an ideal value of hemoglobin or hematocrit which suggests transfusion in cardiac surgeries. The American Society of Anesthesiologists (ASA) recommends that pRBC transfusion in patients with serum level of hemoglobin between 6 and 10 g/dL be based on the risk of developing complications or organic lesion by inappropriate oxygenation [7]. The latest consensus concerning perioperative transfusion in cardiac surgery identified six variables as being important risk indicators of pRBC transfusion: old age, small total amount of red blood cells (anemia or small body size), use of antiplatelet or antithrombotic drugs, reoperation or complex procedures, emergency procedures and non-cardiac comorbidity. This same study stated, with a level A of evidence (class I), that all measures of pre and perioperative blood conservation must be taken into this group of patients, since they correspond to the greatest part of hemocomponent transfusions [8].Among mechanical strategies to reduce the necessity of homologous pRBC transfusion, we find the so-called Cell Saver (CS). It is a specialists' consensual opinion (level C of evidence and class IIb recommendation) that the use of autologous blood transfusion through mechanisms such as Cell Saver is reasonable, during surgeries with cardiopulmonary bypass [8]. However, there are few studies related to the impact of this practice on the real necessity of pRBC transfusion in cardiac surgeries with CPB, especially in coronary artery bypass grafting surgeries. The present study aims to evaluate the impact of Cell Saver on the necessity of pRBC use in coronary artery bypass grafting surgeries associated with miniCPB which were carried out at the University Hospital of Santa Maria (HUSM). METHODSWe carried out a retrospective cross-sectional study in patients who had their health care provided by the Division of Cardiac Surgery of HUSM, undergoing CABG ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.